atherosclerosis cardiovascular disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: SLE patients: - fulfil the American College of Rheumatology criteria for SLE - 20-65 years of age;WG patients: - fulfil the American College of Rheumatology criteria for WG - 20-65 years of age;Patients with essential hypertension - blood pressure of 140/90 mmHg or more - age and sex matched to SLE patients;Healthy controls: - age and sex matched to SLE patients
Exclusion criteria
Exclusion criteria: - pregnancy - diabetes mellitus - renal impairment - MI or sepsis in the past three months - recent surgery - clinical history of cardiovascular disease - cardiovascular conditions that can produce altered blood pressure waveforms: arrythmias, valvular heart disease or congestive heart failure;SLE patients: - Raynaud's phenomenon
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Small Artery Elasticity (SAE), Large Artery Elasticity (LAE), Intima Media Thickness (IMT), EC Activation Markers (TM, sVCAM-1, vWF, homocysteine, oxLDL, hsCRP), Advanced Glycation Endproducts (AGE), Endothelial Progenitor Cells (EPC) | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood count, ALAT, ASAT, creatinin, cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, CRP, blood pressure, pulse rate, BMI, smoking, family history for CVD | — |
Countries
Netherlands